Skip to main content

Table 1 Patient characteristics and baseline clinical assessments

From: Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]

Characteristic Remifentanil Comparator
Number of patients treated 57 48
Medical (%)/post-surgical (%) 49 (88)/7 (13) 44 (92)/4 (8)
Emergency (%)/elective (%) 27 (84)/5 (16), n = 32 21 (91)/2 (9), n = 23
Age (years) 52.2 ± 18.4 57.3 ± 18.1
Male (%)/female (%) 39 (68)/18 (32) 32 (67)/16 (33)
Height (cm) 171.2 ± 9.7 169.0 ± 7.9
Weight (kg) 78.6 ± 13.41 76.3 ± 15.50
SAPS II on admission 43.0 ± 15.6 43.3 ± 11.2
MAP (mmHg)a 88.8 ± 16.5 88.9 ± 14.8
Heart rate (b.p.m.)a 98.9 ± 20.1 95.9 ± 15.5
SAS scorea 3.3 ± 1.3 3.3 ± 1.4
PI scorea 2.0 ± 1.2 2.1 ± 1.1
  1. aBaseline values. Where errors are given, results are means± SD. MAP, mean arterial pressure; PI, pain intensity; SAS, Sedation–Agitation Scale.
\